{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:47:32Z","timestamp":1790524052576,"version":"4.1.0"},"reference-count":249,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T00:00:00Z","timestamp":1506643200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1038\/nrneurol.2017.126","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T14:24:34Z","timestamp":1506695074000},"page":"647-661","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Genome engineering: a new approach to gene therapy for neuromuscular disorders"],"prefix":"10.1038","volume":"13","author":[{"given":"Christopher E.","family":"Nelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline N.","family":"Robinson-Hamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Gersbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,29]]},"reference":[{"key":"BFnrneurol2017126_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.str.2010.12.003","volume":"19","author":"BL Stoddard","year":"2011","unstructured":"Stoddard, B. L. Homing endonucleases: from microbial genetic invaders to reagents for targeted DNA modification. Structure 19, 7\u201315 (2011).","journal-title":"Structure"},{"key":"BFnrneurol2017126_CR2","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nrg2842","volume":"11","author":"FD Urnov","year":"2010","unstructured":"Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S. & Gregory, P. D. Genome editing with engineered zinc finger nucleases. Nat. Rev. Genet. 11, 636\u2013646 (2010).","journal-title":"Nat. Rev. Genet."},{"key":"BFnrneurol2017126_CR3","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1021\/ar500039w","volume":"47","author":"CA Gersbach","year":"2014","unstructured":"Gersbach, C. A., Gaj, T. & Barbas, C. F. 3rd. Synthetic zinc finger proteins: the advent of targeted gene regulation and genome modification technologies. Acc. Chem. Res. 47, 2309\u20132318 (2014).","journal-title":"Acc. Chem. Res."},{"key":"BFnrneurol2017126_CR4","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1126\/science.1204094","volume":"333","author":"AJ Bogdanove","year":"2011","unstructured":"Bogdanove, A. J. & Voytas, D. F. TAL effectors: customizable proteins for DNA targeting. Science 333, 1843\u20131846 (2011).","journal-title":"Science"},{"key":"BFnrneurol2017126_CR5","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","volume":"157","author":"PD Hsu","year":"2014","unstructured":"Hsu, P. D., Lander, E. S. & Zhang, F. Development and applications of CRISPR\u2013Cas9 for genome engineering. Cell 157, 1262\u20131278 (2014).","journal-title":"Cell"},{"key":"BFnrneurol2017126_CR6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm.3793","volume":"21","author":"DB Cox","year":"2015","unstructured":"Cox, D. B., Platt, R. J. & Zhang, F. Therapeutic genome editing: prospects and challenges. Nat. Med. 21, 121\u2013131 (2015).","journal-title":"Nat. Med."},{"key":"BFnrneurol2017126_CR7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/mt.2016.10","volume":"24","author":"ML Maeder","year":"2016","unstructured":"Maeder, M. L. & Gersbach, C. A. Genome-editing technologies for gene and cell therapy. Mol. Ther. 24, 430\u2013446 (2016).","journal-title":"Mol. Ther."},{"key":"BFnrneurol2017126_CR8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature10177","volume":"475","author":"H Li","year":"2011","unstructured":"Li, H.  et al. In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature 475, 217\u2013221 (2011).","journal-title":"Nature"},{"key":"BFnrneurol2017126_CR9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature13420","volume":"510","author":"P Genovese","year":"2014","unstructured":"Genovese, P.  et al. Targeted genome editing in human repopulating haematopoietic stem cells. Nature 510, 235\u2013240 (2014).","journal-title":"Nature"},{"key":"BFnrneurol2017126_CR10","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1300662","volume":"370","author":"P Tebas","year":"2014","unstructured":"Tebas, P.  et al. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N. Engl. J. Med. 370, 901\u2013910 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol2017126_CR11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(11)60756-3","volume":"378","author":"S Cirak","year":"2011","unstructured":"Cirak, S.  et al. Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. Lancet 378, 595\u2013605 (2011).","journal-title":"Lancet"},{"key":"BFnrneurol2017126_CR12","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/mt.2011.237","volume":"20","author":"DE Bowles","year":"2012","unstructured":"Bowles, D. E.  et al. Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector. Mol. Ther. 20, 443\u2013455 (2012).","journal-title":"Mol. Ther."},{"key":"BFnrneurol2017126_CR13","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1056\/NEJMoa073108","volume":"357","author":"JC van Deutekom","year":"2007","unstructured":"van Deutekom, J. C.  et al. Local dystrophin restoration with antisense oligonucleotide PRO051. N. Engl. J. Med. 357, 2677\u20132686 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol2017126_CR14","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1011367","volume":"364","author":"NM Goemans","year":"2011","unstructured":"Goemans, N. M. Systemic administration of PRO051 in Duchenne's muscular dystrophy. N. Engl. J. Med. 364, 1513\u20131522 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol2017126_CR15","doi-asserted-by":"crossref","first-page":"e81302","DOI":"10.1371\/journal.pone.0081302","volume":"8","author":"RS Finkel","year":"2013","unstructured":"Finkel, R. S.  et al. Phase 2a study of ataluren-mediated dystrophin production in patients with nonsense mutation Duchenne muscular dystrophy. PLoS ONE 8, e81302 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrneurol2017126_CR16","doi-asserted-by":"crossref","first-page":"e19189","DOI":"10.1371\/journal.pone.0019189","volume":"6","author":"JM Tinsley","year":"2011","unstructured":"Tinsley, J. M.  et al. Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse. PLoS ONE 6, e19189 (2011).","journal-title":"PLoS ONE"},{"key":"BFnrneurol2017126_CR17","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1073\/pnas.1013067108","volume":"108","author":"AR Amenta","year":"2011","unstructured":"Amenta, A. R.  et al. Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice. Proc. Natl Acad. Sci. USA 108, 762\u2013767 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2017126_CR18","first-page":"25ps15","volume":"2","author":"MJ Wood","year":"2010","unstructured":"Wood, M. J. Toward an oligonucleotide therapy for Duchenne muscular dystrophy: a complex development challenge. Sci. Transl Med. 2, 25ps15 (2010).","journal-title":"Sci. Transl Med."},{"key":"BFnrneurol2017126_CR19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/mt.2010.219","volume":"19","author":"QL Lu","year":"2011","unstructured":"Lu, Q. L.  et al. The status of exon skipping as a therapeutic approach to duchenne muscular dystrophy. Mol. Ther. 19, 9\u201315 (2011).","journal-title":"Mol. Ther."},{"key":"BFnrneurol2017126_CR20","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/WCO.0b013e328357b0be","volume":"25","author":"IE Verhaart","year":"2012","unstructured":"Verhaart, I. E. & Aartsma-Rus, A. Gene therapy for Duchenne muscular dystrophy. Curr. Opin. Neurol. 25, 588\u2013596 (2012).","journal-title":"Curr. Opin. Neurol."},{"key":"BFnrneurol2017126_CR21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1089\/hum.2012.099","volume":"23","author":"H Foster","year":"2012","unstructured":"Foster, H., Popplewell, L. & Dickson, G. Genetic therapeutic approaches for Duchenne muscular dystrophy. Hum. Gene Ther. 23, 676\u2013687 (2012).","journal-title":"Hum. Gene Ther."},{"key":"BFnrneurol2017126_CR22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s40124-014-0044-x","volume":"2","author":"JT Seto","year":"2014","unstructured":"Seto, J. T., Bengtsson, N. E. & Chamberlain, J. S. Therapy of genetic disorders \u2014 novel therapies for Duchenne muscular dystrophy. Curr. Pediatr. Rep. 2, 102\u2013112 (2014).","journal-title":"Curr. Pediatr. Rep."},{"key":"BFnrneurol2017126_CR23","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.pediatrneurol.2014.08.002","volume":"51","author":"S Al-Zaidy","year":"2014","unstructured":"Al-Zaidy, S., Rodino-Klapac, L. & Mendell, J. R. Gene therapy for muscular dystrophy: moving the field forward. Pediatr. Neurol. 51, 607\u2013618 (2014).","journal-title":"Pediatr. Neurol."},{"key":"BFnrneurol2017126_CR24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nrneurol.2015.77","volume":"11","author":"I Faravelli","year":"2015","unstructured":"Faravelli, I., Nizzardo, M., Comi, G. P. & Corti, S. Spinal muscular atrophy \u2014 recent therapeutic advances for an old challenge. Nat. Rev. Neurol. 11, 351\u2013359 (2015).","journal-title":"Nat. Rev. Neurol."},{"key":"BFnrneurol2017126_CR25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2174\/1566523215666150630120537","volume":"15","author":"AF Klein","year":"2015","unstructured":"Klein, A. F., Dastidar, S., Furling, D. & Chuah, M. K. Therapeutic approaches for dominant muscle diseases: highlight on myotonic dystrophy. Curr. Gene Ther. 15, 329\u2013337 (2015).","journal-title":"Curr. Gene Ther."},{"key":"BFnrneurol2017126_CR26","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrneurol.2011.81","volume":"7","author":"CG Bonnemann","year":"2011","unstructured":"Bonnemann, C. G. The collagen VI-related myopathies: muscle meets its matrix. Nat. Rev. Neurol. 7, 379\u2013390 (2011).","journal-title":"Nat. Rev. Neurol."},{"key":"BFnrneurol2017126_CR27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","volume":"10","author":"CA Ross","year":"2014","unstructured":"Ross, C. A.  et al. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat. Rev. Neurol. 10, 204\u2013216 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"BFnrneurol2017126_CR28","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/317230a0","volume":"317","author":"O Smithies","year":"1985","unstructured":"Smithies, O., Gregg, R. G., Boggs, S. S., Koralewski, M. A. & Kucherlapati, R. S. Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination. Nature 317, 230\u2013234 (1985).","journal-title":"Nature"},{"key":"BFnrneurol2017126_CR29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0092-8674(86)90463-0","volume":"44","author":"KR Thomas","year":"1986","unstructured":"Thomas, K. R., Folger, K. R. & Capecchi, M. R. High frequency targeting of genes to specific sites in the mammalian genome. Cell 44, 419\u2013428 (1986).","journal-title":"Cell"},{"key":"BFnrneurol2017126_CR30","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1073\/pnas.91.13.6064","volume":"91","author":"P Rouet","year":"1994","unstructured":"Rouet, P., Smih, F. & Jasin, M. Expression of a site-specific endonuclease stimulates homologous recombination in mammalian cells. Proc. Natl Acad. Sci. USA 91, 6064\u20136068 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2017126_CR31","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1126\/science.1078395","volume":"300","author":"MH Porteus","year":"2003","unstructured":"Porteus, M. H. & Baltimore, D. Chimeric nucleases stimulate gene targeting in human cells. Science 300, 763 (2003).","journal-title":"Science"},{"key":"BFnrneurol2017126_CR32","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1093\/nar\/gkr1214","volume":"40","author":"P Perez-Pinera","year":"2012","unstructured":"Perez-Pinera, P., Ousterout, D. G., Brown, M. T. & Gersbach, C. A. Gene targeting to the ROSA26 locus directed by engineered zinc finger nucleases. Nucleic Acids Res. 40, 3741\u20133752 (2012).","journal-title":"Nucleic Acids Res."},{"key":"BFnrneurol2017126_CR33","doi-asserted-by":"crossref","first-page":"e41796","DOI":"10.1371\/journal.pone.0041796","volume":"7","author":"M Hermann","year":"2012","unstructured":"Hermann, M.  et al. Evaluation of OPEN zinc finger nucleases for direct gene targeting of the ROSA26 locus in mouse embryos. PLoS ONE 7, e41796 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrneurol2017126_CR34","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nbt.1562","volume":"27","author":"D Hockemeyer","year":"2009","unstructured":"Hockemeyer, D.  et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat. Biotechnol. 27, 851\u2013857 (2009).","journal-title":"Nat. Biotechnol."},{"key":"BFnrneurol2017126_CR35","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1101\/gr.106773.110","volume":"20","author":"RC DeKelver","year":"2010","unstructured":"DeKelver, R. C.  et al. Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome. Genome Res. 20, 1133\u20131142 (2010).","journal-title":"Genome Res."},{"key":"BFnrneurol2017126_CR36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1101\/gr.099747.109","volume":"20","author":"HJ Lee","year":"2010","unstructured":"Lee, H. J., Kim, E. & Kim, J. S. Targeted chromosomal deletions in human cells using zinc finger nucleases. Genome Res. 20, 81\u201389 (2010).","journal-title":"Genome Res."},{"key":"BFnrneurol2017126_CR37","doi-asserted-by":"crossref","first-page":"8269","DOI":"10.1093\/nar\/gkq720","volume":"38","author":"C Sollu","year":"2010","unstructured":"Sollu, C.  et al. Autonomous zinc-finger nuclease pairs for targeted chromosomal deletion. Nucleic Acids Res. 38, 8269\u20138276 (2010).","journal-title":"Nucleic Acids Res."},{"key":"BFnrneurol2017126_CR38","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0092-8674(86)90262-X","volume":"44","author":"L Colleaux","year":"1986","unstructured":"Colleaux, L.  et al. Universal code equivalent of a yeast mitochondrial intron reading frame is expressed into E. coli as a specific double strand endonuclease. Cell 44, 521\u2013533 (1986).","journal-title":"Cell"},{"key":"BFnrneurol2017126_CR39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/156652311794520111","volume":"11","author":"G Silva","year":"2011","unstructured":"Silva, G.  et al. Meganucleases and other tools for targeted genome engineering: perspectives and challenges for gene therapy. Curr. Gene Ther. 11, 11\u201327 (2011).","journal-title":"Curr. Gene Ther."},{"key":"BFnrneurol2017126_CR40","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/nar\/gkl645","volume":"34","author":"LE Rosen","year":"2006","unstructured":"Rosen, L. E.  et al. Homing endonuclease I-CreI derivatives with novel DNA target specificities. Nucleic Acids Res. 34, 4791\u20134800 (2006).","journal-title":"Nucleic Acids Res."},{"key":"BFnrneurol2017126_CR41","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1021\/ja057519l","volume":"128","author":"JB Doyon","year":"2006","unstructured":"Doyon, J. B., Pattanayak, V., Meyer, C. B. & Liu, D. R. Directed evolution and substrate specificity profile of homing endonuclease I-SceI. J. Am. Chem. Soc. 128, 2477\u20132484 (2006).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnrneurol2017126_CR42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jmb.2005.10.065","volume":"355","author":"S Arnould","year":"2006","unstructured":"Arnould, S.  et al. Engineering of large numbers of highly specific homing endonucleases that induce recombination on novel DNA targets. J. Mol. Biol. 355, 443\u2013458 (2006).","journal-title":"J. Mol. Biol."},{"key":"BFnrneurol2017126_CR43","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature04818","volume":"441","author":"J Ashworth","year":"2006","unstructured":"Ashworth, J.  et al. Computational redesign of endonuclease DNA binding and cleavage specificity. Nature 441, 656\u2013659 (2006).","journal-title":"Nature"},{"key":"BFnrneurol2017126_CR44","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1146\/annurev.biophys.29.1.183","volume":"29","author":"SA Wolfe","year":"2000","unstructured":"Wolfe, S. A., Nekludova, L. & Pabo, C. O. DNA recognition by Cys2His2 zinc finger proteins. Annu. Rev. Biophys. Biomol. Struct. 29, 183\u2013212 (2000).","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"BFnrneurol2017126_CR45","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1126\/science.2028256","volume":"252","author":"NP Pavletich","year":"1991","unstructured":"Pavletich, N. P. & Pabo, C. O. Zinc finger-DNA recognition: crystal structure of a Zif268\u2013DNA complex at 2.1 A. Science 252, 809\u2013817 (1991).","journal-title":"Science"},{"key":"BFnrneurol2017126_CR46","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1073\/pnas.94.11.5525","volume":"94","author":"Q Liu","year":"1997","unstructured":"Liu, Q., Segal, D. J., Ghiara, J. B. & Barbas, C. F. 3rd. Design of polydactyl zinc-finger proteins for unique addressing within complex genomes. Proc. Natl Acad. Sci. USA 94, 5525\u20135530 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2017126_CR47","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1073\/pnas.93.3.1156","volume":"93","author":"YG Kim","year":"1996","unstructured":"Kim, Y. G., Cha, J. & Chandrasegaran, S. Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc. Natl Acad. Sci. USA 93, 1156\u20131160 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2017126_CR48","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1073\/pnas.040552697","volume":"97","author":"RR Beerli","year":"2000","unstructured":"Beerli, R. R., Dreier, B. & Barbas, C. F. 3rd. Positive and negative regulation of endogenous genes by designed transcription factors. Proc. Natl Acad. Sci. USA 97, 1495\u20131500 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2017126_CR49","doi-asserted-by":"crossref","first-page":"8688","DOI":"10.1073\/pnas.1533177100","volume":"100","author":"A Akopian","year":"2003","unstructured":"Akopian, A., He, J., Boocock, M. R. & Stark, W. M. Chimeric recombinases with designed DNA sequence recognition. Proc. Natl Acad. Sci. USA 100, 8688\u20138691 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2017126_CR50","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1073\/pnas.0812502106","volume":"106","author":"RM Gordley","year":"2009","unstructured":"Gordley, R. M., Gersbach, C. A. & Barbas, C. F. 3rd. Synthesis of programmable integrases. Proc. Natl Acad. Sci. USA 106, 5053\u20135058 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2017126_CR51","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1126\/science.1144956","volume":"318","author":"S Kay","year":"2007","unstructured":"Kay, S., Hahn, S., Marois, E., Hause, G. & Bonas, U. A bacterial effector acts as a plant transcription factor and induces a cell size regulator. Science 318, 648\u2013651 (2007).","journal-title":"Science"},{"key":"BFnrneurol2017126_CR52","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1126\/science.1144958","volume":"318","author":"P Romer","year":"2007","unstructured":"Romer, P.  et al. Plant pathogen recognition mediated by promoter activation of the pepper Bs3 resistance gene. Science 318, 645\u2013648 (2007).","journal-title":"Science"},{"key":"BFnrneurol2017126_CR53","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.1178817","volume":"326","author":"MJ Moscou","year":"2009","unstructured":"Moscou, M. J. & Bogdanove, A. J. A simple cipher governs DNA recognition by TAL effectors. Science 326, 1501 (2009).","journal-title":"Science"},{"key":"BFnrneurol2017126_CR54","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1126\/science.1178811","volume":"326","author":"J Boch","year":"2009","unstructured":"Boch, J.  et al. Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326, 1509\u20131512 (2009).","journal-title":"Science"},{"key":"BFnrneurol2017126_CR55","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1021\/sb400137b","volume":"3","author":"R Moore","year":"2014","unstructured":"Moore, R., Chandrahas, A. & Bleris, L. Transcription activator-like effectors: a toolkit for synthetic biology. ACS Synth. Biol. 3, 708\u2013716 (2014).","journal-title":"ACS Synth. Biol."},{"key":"BFnrneurol2017126_CR56","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1534\/genetics.110.120717","volume":"186","author":"M Christian","year":"2010","unstructured":"Christian, M.  et al. Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 186, 757\u2013761 (2010).","journal-title":"Genetics"},{"key":"BFnrneurol2017126_CR57","doi-asserted-by":"crossref","first-page":"21617","DOI":"10.1073\/pnas.1013133107","volume":"107","author":"R Morbitzer","year":"2010","unstructured":"Morbitzer, R., Romer, P., Boch, J. & Lahaye, T. Regulation of selected genome loci using de novo-engineered transcription activator-like effector (TALE)-type transcription factors. Proc. Natl Acad. Sci. USA 107, 21617\u201321622 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2017126_CR58","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nbt.1755","volume":"29","author":"JC Miller","year":"2011","unstructured":"Miller, J. C.  et al. A TALE nuclease architecture for efficient genome editing. Nat. Biotechnol. 29, 143\u2013148 (2011).","journal-title":"Nat. Biotechnol."},{"key":"BFnrneurol2017126_CR59","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nbt.1775","volume":"29","author":"F Zhang","year":"2011","unstructured":"Zhang, F.  et al. Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat. Biotechnol. 29, 149\u2013153 (2011).","journal-title":"Nat. Biotechnol."},{"key":"BFnrneurol2017126_CR60","doi-asserted-by":"crossref","first-page":"11163","DOI":"10.1093\/nar\/gks875","volume":"40","author":"AC Mercer","year":"2012","unstructured":"Mercer, A. C., Gaj, T., Fuller, R. P. & Barbas, C. F. 3rd. Chimeric TALE recombinases with programmable DNA sequence specificity. Nucleic Acids Res. 40, 11163\u201311172 (2012).","journal-title":"Nucleic Acids Res."},{"key":"BFnrneurol2017126_CR61","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1093\/nar\/gkr218","volume":"39","author":"T Cermak","year":"2011","unstructured":"Cermak, T.  et al. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res. 39, e82 (2011).","journal-title":"Nucleic Acids Res."},{"key":"BFnrneurol2017126_CR62","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.1138140","volume":"315","author":"R Barrangou","year":"2007","unstructured":"Barrangou, R.  et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315, 1709\u20131712 (2007).","journal-title":"Science"},{"key":"BFnrneurol2017126_CR63","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrmicro2577","volume":"9","author":"KS Makarova","year":"2011","unstructured":"Makarova, K. S.  et al. Evolution and classification of the CRISPR-Cas systems. Nat. Rev. Microbiol. 9, 467\u2013477 (2011).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFnrneurol2017126_CR64","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nbt.3659","volume":"34","author":"R Barrangou","year":"2016","unstructured":"Barrangou, R. & Doudna, J. A. Applications of CRISPR technologies in research and beyond. Nat. Biotechnol. 34, 933\u2013941 (2016).","journal-title":"Nat. Biotechnol."},{"key":"BFnrneurol2017126_CR65","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1126\/science.1159689","volume":"321","author":"SJ Brouns","year":"2008","unstructured":"Brouns, S. J.  et al. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321, 960\u2013964 (2008).","journal-title":"Science"},{"key":"BFnrneurol2017126_CR66","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nature09886","volume":"471","author":"E Deltcheva","year":"2011","unstructured":"Deltcheva, E.  et al. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471, 602\u2013607 (2011).","journal-title":"Nature"},{"key":"BFnrneurol2017126_CR67","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek, M.  et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816\u2013821 (2012).","journal-title":"Science"},{"key":"BFnrneurol2017126_CR68","doi-asserted-by":"crossref","first-page":"1258096","DOI":"10.1126\/science.1258096","volume":"346","author":"JA Doudna","year":"2014","unstructured":"Doudna, J. A. & Charpentier, E. Genome editing. The new frontier of genome engineering with CRISPR\u2013Cas9. Science 346, 1258096 (2014).","journal-title":"Science"},{"key":"BFnrneurol2017126_CR69","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nature13166","volume":"509","author":"Y Zhou","year":"2014","unstructured":"Zhou, Y.  et al. High-throughput screening of a CRISPR\/Cas9 library for functional genomics in human cells. Nature 509, 487\u2013491 (2014).","journal-title":"Nature"},{"key":"BFnrneurol2017126_CR70","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nbt.2800","volume":"32","author":"H Koike-Yusa","year":"2014","unstructured":"Koike-Yusa, H., Li, Y., Tan, E. P., Velasco-Herrera Mdel, C. & Yusa, K. Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat. Biotechnol. 32, 267\u2013273 (2014).","journal-title":"Nat. Biotechnol."},{"key":"BFnrneurol2017126_CR71","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1247005","volume":"343","author":"O Shalem","year":"2014","unstructured":"Shalem, O.  et al. Genome-scale CRISPR\u2013Cas9 knockout screening in human cells. Science 343, 84\u201387 (2014).","journal-title":"Science"},{"key":"BFnrneurol2017126_CR72","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.1246981","volume":"343","author":"T Wang","year":"2014","unstructured":"Wang, T., Wei, J. J., Sabatini, D. M. & Lander, E. S. Genetic screens in human cells using the CRISPR\u2013Cas9 system. Science 343, 80\u201384 (2014).","journal-title":"Science"},{"key":"BFnrneurol2017126_CR73","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nmeth.3733","volume":"13","author":"PI Thakore","year":"2016","unstructured":"Thakore, P. I., Black, J. B., Hilton, I. B. & Gersbach, C. A. Editing the epigenome: technologies for programmable transcription and epigenetic modulation. Nat. Methods 13, 127\u2013137 (2016).","journal-title":"Nat. Methods"},{"key":"BFnrneurol2017126_CR74","doi-asserted-by":"crossref","first-page":"14628","DOI":"10.1073\/pnas.95.25.14628","volume":"95","author":"RR Beerli","year":"1998","unstructured":"Beerli, R. R., Segal, D. J., Dreier, B. & Barbas, C. F. 3rd. Toward controlling gene expression at will: specific regulation of the erbB-2\/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks. Proc. Natl Acad. Sci. USA 95, 14628\u201314633 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2017126_CR75","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","volume":"154","author":"LA Gilbert","year":"2013","unstructured":"Gilbert, L. A.  et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154, 442\u2013451 (2013).","journal-title":"Cell"},{"key":"BFnrneurol2017126_CR76","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nmeth.2598","volume":"10","author":"ML Maeder","year":"2013","unstructured":"Maeder, M. L.  et al. CRISPR RNA-guided activation of endogenous human genes. Nat. Methods 10, 977\u2013979 (2013).","journal-title":"Nat. Methods"},{"key":"BFnrneurol2017126_CR77","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nmeth.2600","volume":"10","author":"P Perez-Pinera","year":"2013","unstructured":"Perez-Pinera, P.  et al. RNA-guided gene activation by CRISPR\u2013Cas9-based transcription factors. Nat. Methods 10, 973\u2013976 (2013).","journal-title":"Nat. Methods"},{"key":"BFnrneurol2017126_CR78","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/ncomms1962","volume":"3","author":"L Cong","year":"2012","unstructured":"Cong, L., Zhou, R., Kuo, Y. C., Cunniff, M. & Zhang, F. Comprehensive interrogation of natural TALE DNA-binding modules and transcriptional repressor domains. Nat. Commun. 3, 968 (2012).","journal-title":"Nat. Commun."},{"key":"BFnrneurol2017126_CR79","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/nmeth.3630","volume":"12","author":"PI Thakore","year":"2015","unstructured":"Thakore, P. I.  et al. Highly specific epigenome editing by CRISPR\u2013Cas9 repressors for silencing of distal regulatory elements. Nat. Methods 12, 1143\u20131149 (2015).","journal-title":"Nat. Methods"},{"key":"BFnrneurol2017126_CR80","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.1093\/nar\/gkg853","volume":"31","author":"CD Carvin","year":"2003","unstructured":"Carvin, C. D., Parr, R. D. & Kladde, M. P. Site-selective in vivo targeting of cytosine-5 DNA methylation by zinc-finger proteins. Nucleic Acids Res. 31, 6493\u20136501 (2003).","journal-title":"Nucleic Acids Res."},{"key":"BFnrneurol2017126_CR81","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/nbt.2726","volume":"31","author":"ML Maeder","year":"2013","unstructured":"Maeder, M. L.  et al. Targeted DNA demethylation and activation of endogenous genes using programmable TALE\u2013TET1 fusion proteins. Nat. Biotechnol. 31, 1137\u20131142 (2013).","journal-title":"Nat. Biotechnol."},{"key":"BFnrneurol2017126_CR82","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nbt.3199","volume":"33","author":"IB Hilton","year":"2015","unstructured":"Hilton, I. B.  et al. Epigenome editing by a CRISPR\u2013Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat. Biotechnol. 33, 510\u2013517 (2015).","journal-title":"Nat. Biotechnol."},{"key":"BFnrneurol2017126_CR83","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.cell.2013.04.025","volume":"153","author":"H Wang","year":"2013","unstructured":"Wang, H.  et al. One-step generation of mice carrying mutations in multiple genes by CRISPR\/Cas-mediated genome engineering. Cell 153, 910\u2013918 (2013).","journal-title":"Cell"},{"key":"BFnrneurol2017126_CR84","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.3390\/ijms17101668","volume":"17","author":"HH Yu","year":"2016","unstructured":"Yu, H. H.  et al. Porcine zygote injection with Cas9\/sgRNA results in DMD-modified pig with muscle dystrophy. Int. J. Mol. Sci. 17, 1668 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"BFnrneurol2017126_CR85","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1093\/hmg\/ddv120","volume":"24","author":"Y Chen","year":"2015","unstructured":"Chen, Y.  et al. Functional disruption of the dystrophin gene in rhesus monkey using CRISPR\/Cas9. Hum. Mol. Genet. 24, 3764\u20133774 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol2017126_CR86","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/s00595-009-4242-z","volume":"40","author":"B Palmieri","year":"2010","unstructured":"Palmieri, B. & Tremblay, J. P. Myoblast transplantation: a possible surgical treatment for a severe pediatric disease. Surg. Today 40, 902\u2013908 (2010).","journal-title":"Surg. Today"},{"key":"BFnrneurol2017126_CR87","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.stem.2012.02.015","volume":"10","author":"R Darabi","year":"2012","unstructured":"Darabi, R.  et al. Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice. Cell Stem Cell 10, 610\u2013619 (2012).","journal-title":"Cell Stem Cell"},{"key":"BFnrneurol2017126_CR88","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/mt.2013.59","volume":"21","author":"L Riolobos","year":"2013","unstructured":"Riolobos, L.  et al. HLA engineering of human pluripotent stem cells. Mol. Ther. 21, 1232\u20131241 (2013).","journal-title":"Mol. Ther."},{"key":"BFnrneurol2017126_CR89","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.stemcr.2014.10.013","volume":"4","author":"HL Li","year":"2015","unstructured":"Li, H. L.  et al. Precise correction of the dystrophin gene in Duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR\u2013Cas9. Stem Cell Rep. 4, 143\u2013154 (2015).","journal-title":"Stem Cell Rep."},{"key":"BFnrneurol2017126_CR90","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.stem.2016.01.021","volume":"18","author":"CS Young","year":"2016","unstructured":"Young, C. S.  et al. A single CRISPR\u2013Cas9 deletion strategy that targets the majority of DMD patients restores dystrophin function in hiPSC-derived muscle cells. Cell Stem Cell 18, 533\u2013540 (2016).","journal-title":"Cell Stem Cell"},{"key":"BFnrneurol2017126_CR91","doi-asserted-by":"crossref","first-page":"e96279","DOI":"10.1371\/journal.pone.0096279","volume":"9","author":"C Zhao","year":"2014","unstructured":"Zhao, C.  et al. Recombinase-mediated reprogramming and dystrophin gene addition in mdx mouse induced pluripotent stem cells. PLoS ONE 9, e96279 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrneurol2017126_CR92","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13073-016-0316-x","volume":"8","author":"I Maggio","year":"2016","unstructured":"Maggio, I., Chen, X. Y. & Goncalves, M. A. The emerging role of viral vectors as vehicles for DMD gene editing. Genome Med. 8, 59 (2016).","journal-title":"Genome Med."},{"key":"BFnrneurol2017126_CR93","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/S0140-6736(12)61992-8","volume":"380","author":"K Gruber","year":"2012","unstructured":"Gruber, K. Europe gives gene therapy the green light. Lancet 380, e10 (2012).","journal-title":"Lancet"},{"key":"BFnrneurol2017126_CR94","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1182\/blood-2003-05-1446","volume":"103","author":"VR Arruda","year":"2004","unstructured":"Arruda, V. R.  et al. Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1. Blood 103, 85\u201392 (2004).","journal-title":"Blood"},{"key":"BFnrneurol2017126_CR95","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nbt1073","volume":"23","author":"Z Wang","year":"2005","unstructured":"Wang, Z.  et al. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat. Biotechnol. 23, 321\u2013328 (2005).","journal-title":"Nat. Biotechnol."},{"key":"BFnrneurol2017126_CR96","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ymthe.2006.03.014","volume":"14","author":"K Inagaki","year":"2006","unstructured":"Inagaki, K.  et al. Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. Mol. Ther. 14, 45\u201353 (2006).","journal-title":"Mol. Ther."},{"key":"BFnrneurol2017126_CR97","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ymthe.2006.05.009","volume":"14","author":"Z Wu","year":"2006","unstructured":"Wu, Z., Asokan, A. & Samulski, R. J. Adeno-associated virus serotypes: vector toolkit for human gene therapy. Mol. Ther. 14, 316\u2013327 (2006).","journal-title":"Mol. Ther."},{"key":"BFnrneurol2017126_CR98","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/mt.2011.287","volume":"20","author":"A Asokan","year":"2012","unstructured":"Asokan, A., Schaffer, D. V. & Samulski, R. J. The AAV vector toolkit: poised at the clinical crossroads. Mol. Ther. 20, 699\u2013708 (2012).","journal-title":"Mol. Ther."},{"key":"BFnrneurol2017126_CR99","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1146\/annurev.genet.37.110801.143717","volume":"38","author":"DM McCarty","year":"2004","unstructured":"McCarty, D. M., Young Jr, S. M. & Samulski, R. J. Integration of adeno-associated virus (AAV) and recombinant AAV vectors. Annu. Rev. Genet. 38, 819\u2013845 (2004).","journal-title":"Annu. Rev. Genet."},{"key":"BFnrneurol2017126_CR100","first-page":"442","volume":"11","author":"DR Deyle","year":"2009","unstructured":"Deyle, D. R. & Russell, D. W. Adeno-associated virus vector integration. Curr. Opin. Mol. Ther. 11, 442\u2013447 (2009).","journal-title":"Curr. Opin. Mol. Ther."},{"key":"BFnrneurol2017126_CR101","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/156652312800840603","volume":"12","author":"JT Seto","year":"2012","unstructured":"Seto, J. T., Ramos, J. N., Muir, L., Chamberlain, J. S. & Odom, G. L. Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors. Curr. Gene Ther. 12, 139\u2013151 (2012).","journal-title":"Curr. Gene Ther."},{"key":"BFnrneurol2017126_CR102","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/mt.2009.255","volume":"18","author":"Z Wu","year":"2010","unstructured":"Wu, Z., Yang, H. & Colosi, P. Effect of genome size on AAV vector packaging. Mol. Ther. 18, 80\u201386 (2010).","journal-title":"Mol. Ther."},{"key":"BFnrneurol2017126_CR103","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","volume":"520","author":"FA Ran","year":"2015","unstructured":"Ran, F. A.  et al. In vivo genome editing using Staphylococcus aureus Cas9. Nature 520, 186\u2013191 (2015).","journal-title":"Nature"},{"key":"BFnrneurol2017126_CR104","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrg3742","volume":"15","author":"MA Kotterman","year":"2014","unstructured":"Kotterman, M. A. & Schaffer, D. V. Engineering adeno-associated viruses for clinical gene therapy. Nat. Rev. Genet. 15, 445\u2013451 (2014).","journal-title":"Nat. Rev. Genet."},{"key":"BFnrneurol2017126_CR105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nbt1182","volume":"24","author":"N Maheshri","year":"2006","unstructured":"Maheshri, N., Koerber, J. T., Kaspar, B. K. & Schaffer, D. V. Directed evolution of adeno-associated virus yields enhanced gene delivery vectors. Nat. Biotechnol. 24, 198\u2013204 (2006).","journal-title":"Nat. Biotechnol."},{"key":"BFnrneurol2017126_CR106","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/mt.2008.100","volume":"16","author":"W Li","year":"2008","unstructured":"Li, W.  et al. Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles. Mol. Ther. 16, 1252\u20131260 (2008).","journal-title":"Mol. Ther."},{"key":"BFnrneurol2017126_CR107","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nbt.1599","volume":"28","author":"A Asokan","year":"2010","unstructured":"Asokan, A.  et al. Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle. Nat. Biotechnol. 28, 79\u201382 (2010).","journal-title":"Nat. Biotechnol."},{"key":"BFnrneurol2017126_CR108","doi-asserted-by":"crossref","first-page":"28814","DOI":"10.1074\/jbc.M113.482380","volume":"288","author":"S Shen","year":"2013","unstructured":"Shen, S.  et al. Engraftment of a galactose receptor footprint onto adeno-associated viral capsids improves transduction efficiency. J. Biol. Chem. 288, 28814\u201328823 (2013).","journal-title":"J. Biol. Chem."},{"key":"BFnrneurol2017126_CR109","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1073\/pnas.0813207106","volume":"106","author":"L Yang","year":"2009","unstructured":"Yang, L.  et al. A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection. Proc. Natl Acad. Sci. USA 106, 3946\u20133951 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2017126_CR110","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/biot.201400529","volume":"10","author":"F Schmidt","year":"2015","unstructured":"Schmidt, F. & Grimm, D. CRISPR genome engineering and viral gene delivery: a case of mutual attraction. Biotechnol. J. 10, 258\u2013272 (2015).","journal-title":"Biotechnol. J."},{"key":"BFnrneurol2017126_CR111","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.aad5143","volume":"351","author":"CE Nelson","year":"2016","unstructured":"Nelson, C. E.  et al. In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Science 351, 403\u2013407 (2016).","journal-title":"Science"},{"key":"BFnrneurol2017126_CR112","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.aad5177","volume":"351","author":"M Tabebordbar","year":"2016","unstructured":"Tabebordbar, M.  et al. In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science 351, 407\u2013411 (2016).","journal-title":"Science"},{"key":"BFnrneurol2017126_CR113","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.aad5725","volume":"351","author":"C Long","year":"2016","unstructured":"Long, C.  et al. Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science 351, 400\u2013403 (2016).","journal-title":"Science"},{"key":"BFnrneurol2017126_CR114","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/nbt1353","volume":"25","author":"A Lombardo","year":"2007","unstructured":"Lombardo, A.  et al. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat. Biotechnol. 25, 1298\u20131306 (2007).","journal-title":"Nat. Biotechnol."},{"key":"BFnrneurol2017126_CR115","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/mt.2010.70","volume":"18","author":"DA Persons","year":"2010","unstructured":"Persons, D. A. Lentiviral vector gene therapy: effective and safe? Mol. Ther. 18, 861\u2013862 (2010).","journal-title":"Mol. Ther."},{"key":"BFnrneurol2017126_CR116","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1093\/nar\/gku749","volume":"42","author":"AM Kabadi","year":"2014","unstructured":"Kabadi, A. M., Ousterout, D. G., Hilton, I. B. & Gersbach, C. A. Multiplex CRISPR\/Cas9-based genome engineering from a single lentiviral vector. Nucleic Acids Res. 42, e147 (2014).","journal-title":"Nucleic Acids Res."},{"key":"BFnrneurol2017126_CR117","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1093\/nar\/gkr524","volume":"39","author":"A Izmiryan","year":"2011","unstructured":"Izmiryan, A., Basmaciogullari, S., Henry, A., Paques, F. & Danos, O. Efficient gene targeting mediated by a lentiviral vector-associated meganuclease. Nucleic Acids Res. 39, 7610\u20137619 (2011).","journal-title":"Nucleic Acids Res."},{"key":"BFnrneurol2017126_CR118","doi-asserted-by":"crossref","first-page":"e01911","DOI":"10.7554\/eLife.01911","volume":"3","author":"Y Cai","year":"2014","unstructured":"Cai, Y., Bak, R. O. & Mikkelsen, J. G. Targeted genome editing by lentiviral protein transduction of zinc-finger and TAL-effector nucleases. eLife 3, e01911 (2014).","journal-title":"eLife"},{"key":"BFnrneurol2017126_CR119","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1093\/nar\/gks1446","volume":"41","author":"M Holkers","year":"2013","unstructured":"Holkers, M.  et al. Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells. Nucleic Acids Res. 41, e63 (2013).","journal-title":"Nucleic Acids Res."},{"key":"BFnrneurol2017126_CR120","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1089\/hum.2015.087","volume":"26","author":"D Wang","year":"2015","unstructured":"Wang, D.  et al. Adenovirus-mediated somatic genome editing of Pten by CRISPR\/Cas9 in mouse liver in spite of Cas9-specific immune responses. Hum. Gene Ther. 26, 432\u2013442 (2015).","journal-title":"Hum. Gene Ther."},{"key":"BFnrneurol2017126_CR121","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymgme.2003.08.016","volume":"80","author":"SE Raper","year":"2003","unstructured":"Raper, S. E.  et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol. Genet. Metab. 80, 148\u2013158 (2003).","journal-title":"Mol. Genet. Metab."},{"key":"BFnrneurol2017126_CR122","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/sj.gt.3301251","volume":"7","author":"SB Geutskens","year":"2000","unstructured":"Geutskens, S. B.  et al. Recombinant adenoviral vectors have adjuvant activity and stimulate T cell responses against tumor cells. Gene Ther. 7, 1410\u20131416 (2000).","journal-title":"Gene Ther."},{"key":"BFnrneurol2017126_CR123","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrg1577","volume":"6","author":"DJ Glover","year":"2005","unstructured":"Glover, D. J., Lipps, H. J. & Jans, D. A. Towards safe, non-viral therapeutic gene expression in humans. Nat. Rev. Genet. 6, 299\u2013310 (2005).","journal-title":"Nat. Rev. Genet."},{"key":"BFnrneurol2017126_CR124","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1146\/annurev-chembioeng-080615-034711","volume":"7","author":"CE Nelson","year":"2016","unstructured":"Nelson, C. E. & Gersbach, C. A. Engineering delivery vehicles for genome editing. Annu. Rev. Chem. Biomol. Eng. 7, 637\u2013662 (2016).","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"key":"BFnrneurol2017126_CR125","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","volume":"15","author":"H Yin","year":"2014","unstructured":"Yin, H.  et al. Non-viral vectors for gene-based therapy. Nat. Rev. Genet. 15, 541\u2013555 (2014).","journal-title":"Nat. Rev. Genet."},{"key":"BFnrneurol2017126_CR126","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1089\/hum.2010.160","volume":"22","author":"CI Wooddell","year":"2011","unstructured":"Wooddell, C. I.  et al. Dose response in rodents and nonhuman primates after hydrodynamic limb vein delivery of naked plasmid DNA. Hum. Gene Ther. 22, 889\u2013903 (2011).","journal-title":"Hum. Gene Ther."},{"key":"BFnrneurol2017126_CR127","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1089\/hum.2009.133","volume":"21","author":"G Zhang","year":"2010","unstructured":"Zhang, G.  et al. Functional efficacy of dystrophin expression from plasmids delivered to mdx mice by hydrodynamic limb vein injection. Hum. Gene Ther. 21, 221\u2013237 (2010).","journal-title":"Hum. Gene Ther."},{"key":"BFnrneurol2017126_CR128","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/sj.gt.3301874","volume":"10","author":"QL Lu","year":"2003","unstructured":"Lu, Q. L., Bou-Gharios, G. & Partridge, T. A. Non-viral gene delivery in skeletal muscle: a protein factory. Gene Ther. 10, 131\u2013142 (2003).","journal-title":"Gene Ther."},{"key":"BFnrneurol2017126_CR129","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nbt.2884","volume":"32","author":"H Yin","year":"2014","unstructured":"Yin, H.  et al. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat. Biotechnol. 32, 551\u2013553 (2014).","journal-title":"Nat. Biotechnol."},{"key":"BFnrneurol2017126_CR130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbadis.2006.07.009","volume":"1772","author":"TA Rando","year":"2007","unstructured":"Rando, T. A. Non-viral gene therapy for Duchenne muscular dystrophy: progress and challenges. Biochim. Biophys. Acta 1772, 263\u2013271 (2007).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrneurol2017126_CR131","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/gt.2012.82","volume":"20","author":"NA McNeer","year":"2013","unstructured":"McNeer, N. A.  et al. Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo. Gene Ther. 20, 658\u2013669 (2013).","journal-title":"Gene Ther."},{"key":"BFnrneurol2017126_CR132","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nbt.3081","volume":"33","author":"JA Zuris","year":"2015","unstructured":"Zuris, J. A.  et al. Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat. Biotechnol. 33, 73\u201380 (2015).","journal-title":"Nat. Biotechnol."},{"key":"BFnrneurol2017126_CR133","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jamaneurol.2016.3388","volume":"73","author":"C Long","year":"2016","unstructured":"Long, C., Amoasii, L., Bassel-Duby, R. & Olson, E. N. Genome editing of monogenic neuromuscular diseases: a systematic review. JAMA Neurol. 73, 1349\u20131355 (2016).","journal-title":"JAMA Neurol."},{"key":"BFnrneurol2017126_CR134","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00439-016-1725-z","volume":"135","author":"JN Robinson-Hamm","year":"2016","unstructured":"Robinson-Hamm, J. N. & Gersbach, C. A. Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy. Hum. Genet. 135, 1029\u20131040 (2016).","journal-title":"Hum. Genet."},{"key":"BFnrneurol2017126_CR135","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nrm2024","volume":"7","author":"KE Davies","year":"2006","unstructured":"Davies, K. E. & Nowak, K. J. Molecular mechanisms of muscular dystrophies: old and new players. Nat. Rev. Mol. Cell Biol. 7, 762\u2013773 (2006).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnrneurol2017126_CR136","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/jmg.15.5.339","volume":"15","author":"AM Davie","year":"1978","unstructured":"Davie, A. M. & Emery, A. E. Estimation of proportion of new mutants among cases of Duchenne muscular dystrophy. J. Med. Genet. 15, 339\u2013345 (1978).","journal-title":"J. Med. Genet."},{"key":"BFnrneurol2017126_CR137","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby, K.  et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 9, 77\u201393 (2010).","journal-title":"Lancet Neurol."},{"key":"BFnrneurol2017126_CR138","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/mus.23942","volume":"49","author":"J Larkindale","year":"2014","unstructured":"Larkindale, J.  et al. Cost of illness for neuromuscular diseases in the United States. Muscle Nerve 49, 431\u2013438 (2014).","journal-title":"Muscle Nerve"},{"key":"BFnrneurol2017126_CR139","doi-asserted-by":"crossref","first-page":"13714","DOI":"10.1073\/pnas.240335297","volume":"97","author":"B Wang","year":"2000","unstructured":"Wang, B., Li, J. & Xiao, X. Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model. Proc. Natl Acad. Sci. USA 97, 13714\u201313719 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2017126_CR140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ymthe.2004.09.013","volume":"11","author":"M Liu","year":"2005","unstructured":"Liu, M.  et al. Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury. Mol. Ther. 11, 245\u2013256 (2005).","journal-title":"Mol. Ther."},{"key":"BFnrneurol2017126_CR141","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1089\/hum.2011.131","volume":"23","author":"Y Zhang","year":"2012","unstructured":"Zhang, Y. & Duan, D. Novel mini\u2013dystrophin gene dual adeno-associated virus vectors restore neuronal nitric oxide synthase expression at the sarcolemma. Hum. Gene Ther. 23, 98\u2013103 (2012).","journal-title":"Hum. Gene Ther."},{"key":"BFnrneurol2017126_CR142","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/humu.20918","volume":"30","author":"A Aartsma-Rus","year":"2009","unstructured":"Aartsma-Rus, A.  et al. Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations. Hum. Mutat. 30, 293\u2013299 (2009).","journal-title":"Hum. Mutat."},{"key":"BFnrneurol2017126_CR143","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1126\/science.1104297","volume":"306","author":"A Goyenvalle","year":"2004","unstructured":"Goyenvalle, A.  et al. Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping. Science 306, 1796\u20131799 (2004).","journal-title":"Science"},{"key":"BFnrneurol2017126_CR144","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ana.24555","volume":"79","author":"JR Mendell","year":"2016","unstructured":"Mendell, J. R.  et al. Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy. Ann. Neurol. 79, 257\u2013271 (2016).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2017126_CR145","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nm.3765","volume":"21","author":"A Goyenvalle","year":"2015","unstructured":"Goyenvalle, A.  et al. Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers. Nat. Med. 21, 270\u2013275 (2015).","journal-title":"Nat. Med."},{"key":"BFnrneurol2017126_CR146","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/gt.2010.26","volume":"17","author":"P Chapdelaine","year":"2010","unstructured":"Chapdelaine, P., Pichavant, C., Rousseau, J., Paques, F. & Tremblay, J. P. Meganucleases can restore the reading frame of a mutated dystrophin. Gene Ther. 17, 846\u2013858 (2010).","journal-title":"Gene Ther."},{"key":"BFnrneurol2017126_CR147","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1089\/hum.2013.081","volume":"24","author":"L Popplewell","year":"2013","unstructured":"Popplewell, L.  et al. Gene correction of a Duchenne muscular dystrophy mutation by meganuclease-enhanced exon knock-in. Hum. Gene Ther. 24, 692\u2013701 (2013).","journal-title":"Hum. Gene Ther."},{"key":"BFnrneurol2017126_CR148","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/mt.2014.234","volume":"23","author":"DG Ousterout","year":"2015","unstructured":"Ousterout, D. G.  et al. Correction of dystrophin expression in cells from Duchenne muscular dystrophy patients through genomic excision of exon 51 by zinc finger nucleases. Mol. Ther. 23, 523\u2013532 (2015).","journal-title":"Mol. Ther."},{"key":"BFnrneurol2017126_CR149","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1038\/mt.2013.111","volume":"21","author":"DG Ousterout","year":"2013","unstructured":"Ousterout, D. G.  et al. Reading frame correction by targeted genome editing restores dystrophin expression in cells from Duchenne muscular dystrophy patients. Mol. Ther. 21, 1718\u20131726 (2013).","journal-title":"Mol. Ther."},{"key":"BFnrneurol2017126_CR150","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1038\/ncomms7244","volume":"6","author":"DG Ousterout","year":"2015","unstructured":"Ousterout, D. G.  et al. Multiplex CRISPR\/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy. Nat. Commun. 6, 6244 (2015).","journal-title":"Nat. Commun."},{"key":"BFnrneurol2017126_CR151","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/nar\/gkv1540","volume":"44","author":"I Maggio","year":"2016","unstructured":"Maggio, I.  et al. Selection-free gene repair after adenoviral vector transduction of designer nucleases: rescue of dystrophin synthesis in DMD muscle cell populations. Nucleic Acids Res. 44, 1449\u20131470 (2016).","journal-title":"Nucleic Acids Res."},{"key":"BFnrneurol2017126_CR152","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1038\/mtna.2015.58","volume":"5","author":"JP Iyombe-Engembe","year":"2016","unstructured":"Iyombe-Engembe, J. P.  et al. Efficient restoration of the dystrophin gene reading frame and protein structure in DMD myoblasts using the CinDel method. Mol. Ther. Nucleic Acids 5, e283 (2016).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"BFnrneurol2017126_CR153","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/mt.2015.192","volume":"24","author":"L Xu","year":"2015","unstructured":"Xu, L.  et al. CRISPR-mediated genome editing restores dystrophin expression and function in mdx mice. Mol. Ther. 24, 564\u2013569 (2015).","journal-title":"Mol. Ther."},{"key":"BFnrneurol2017126_CR154","doi-asserted-by":"crossref","first-page":"14454","DOI":"10.1038\/ncomms14454","volume":"8","author":"NE Bengtsson","year":"2017","unstructured":"Bengtsson, N. E.  et al. Muscle-specific CRISPR\/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy. Nat. Commun. 8, 14454 (2017).","journal-title":"Nat. Commun."},{"key":"BFnrneurol2017126_CR155","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/ajh.24543","volume":"91","author":"J Hartmann","year":"2016","unstructured":"Hartmann, J. & Croteau, S. E. 2017 clinical trials update: innovations in hemophilia therapy. Am. J. Hematol. 91, 1252\u20131260 (2016).","journal-title":"Am. J. Hematol."},{"key":"BFnrneurol2017126_CR156","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nature20565","volume":"540","author":"K Suzuki","year":"2016","unstructured":"Suzuki, K.  et al. In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration. Nature 540, 144\u2013149 (2016).","journal-title":"Nature"},{"key":"BFnrneurol2017126_CR157","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1016\/j.febslet.2014.09.014","volume":"588","author":"P Kasparek","year":"2014","unstructured":"Kasparek, P.  et al. Efficient gene targeting of the Rosa26 locus in mouse zygotes using TALE nucleases. FEBS Lett. 588, 3982\u20133988 (2014).","journal-title":"FEBS Lett."},{"key":"BFnrneurol2017126_CR158","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1101\/gr.171538.113","volume":"24","author":"S Remy","year":"2014","unstructured":"Remy, S.  et al. Efficient gene targeting by homology-directed repair in rat zygotes using TALE nucleases. Genome Res. 24, 1371\u20131383 (2014).","journal-title":"Genome Res."},{"key":"BFnrneurol2017126_CR159","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.stemcr.2015.05.011","volume":"5","author":"T Sato","year":"2015","unstructured":"Sato, T.  et al. Genome editing in mouse spermatogonial stem cell lines using TALEN and double-nicking CRISPR\/Cas9. Stem Cell Rep. 5, 75\u201382 (2015).","journal-title":"Stem Cell Rep."},{"key":"BFnrneurol2017126_CR160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.fob.2015.03.003","volume":"5","author":"RM Quadros","year":"2015","unstructured":"Quadros, R. M., Harms, D. W., Ohtsuka, M. & Gurumurthy, C. B. Insertion of sequences at the original provirus integration site of mouse ROSA26 locus using the CRISPR\/Cas9 system. FEBS Open Bio 5, 191\u2013197 (2015).","journal-title":"FEBS Open Bio"},{"key":"BFnrneurol2017126_CR161","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1038\/mtna.2012.55","volume":"2","author":"BF Benabdallah","year":"2013","unstructured":"Benabdallah, B. F.  et al. Targeted gene addition of microdystrophin in mice skeletal muscle via human myoblast transplantation. Mol. Ther. Nucleic Acids 2, e68 (2013).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"BFnrneurol2017126_CR162","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/jcph.468","volume":"55","author":"J Tinsley","year":"2015","unstructured":"Tinsley, J., Robinson, N. & Davies, K. E. Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to healthy male adult volunteers. J. Clin. Pharmacol. 55, 698\u2013707 (2015).","journal-title":"J. Clin. Pharmacol."},{"key":"BFnrneurol2017126_CR163","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/sj.gt.3301204","volume":"7","author":"N Corbi","year":"2000","unstructured":"Corbi, N.  et al. The artificial zinc finger coding gene 'Jazz' binds the utrophin promoter and activates transcription. Gene Ther. 7, 1076\u20131083 (2000).","journal-title":"Gene Ther."},{"key":"BFnrneurol2017126_CR164","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/hmg\/ddp539","volume":"19","author":"MG Di Certo","year":"2010","unstructured":"Di Certo, M. G.  et al. The artificial gene Jazz, a transcriptional regulator of utrophin, corrects the dystrophic pathology in mdx mice. Hum. Mol. Genet. 19, 752\u2013760 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol2017126_CR165","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/jcp.24567","volume":"229","author":"G Strimpakos","year":"2014","unstructured":"Strimpakos, G.  et al. Novel adeno-associated viral vector delivering the utrophin gene regulator Jazz counteracts dystrophic pathology in mdx mice. J. Cell. Physiol. 229, 1283\u20131291 (2014).","journal-title":"J. Cell. Physiol."},{"key":"BFnrneurol2017126_CR166","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1139\/O07-015","volume":"85","author":"A Onori","year":"2007","unstructured":"Onori, A.  et al. The artificial 4-zinc-finger protein Bagly binds human utrophin promoter A at the endogenous chromosomal site and activates transcription. Biochem. Cell Biol. 85, 358\u2013365 (2007).","journal-title":"Biochem. Cell Biol."},{"key":"BFnrneurol2017126_CR167","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2199-14-3","volume":"14","author":"A Onori","year":"2013","unstructured":"Onori, A.  et al. UtroUp is a novel six zinc finger artificial transcription factor that recognises 18 base pairs of the utrophin promoter and efficiently drives utrophin upregulation. BMC Mol. Biol. 14, 3 (2013).","journal-title":"BMC Mol. Biol."},{"key":"BFnrneurol2017126_CR168","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","volume":"27","author":"KD Foust","year":"2009","unstructured":"Foust, K. D.  et al. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat. Biotechnol. 27, 59\u201365 (2009).","journal-title":"Nat. Biotechnol."},{"key":"BFnrneurol2017126_CR169","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/mt.2009.71","volume":"17","author":"S Duque","year":"2009","unstructured":"Duque, S.  et al. Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons. Mol. Ther. 17, 1187\u20131196 (2009).","journal-title":"Mol. Ther."},{"key":"BFnrneurol2017126_CR170","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","volume":"28","author":"KD Foust","year":"2010","unstructured":"Foust, K. D.  et al. Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat. Biotechnol. 28, 271\u2013274 (2010).","journal-title":"Nat. Biotechnol."},{"key":"BFnrneurol2017126_CR171","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.yexcr.2007.10.012","volume":"314","author":"D DiMatteo","year":"2008","unstructured":"DiMatteo, D., Callahan, S. & Kmiec, E. B. Genetic conversion of an SMN2 gene to SMN1: a novel approach to the treatment of spinal muscular atrophy. Exp. Cell Res. 314, 878\u2013886 (2008).","journal-title":"Exp. Cell Res."},{"key":"BFnrneurol2017126_CR172","doi-asserted-by":"crossref","first-page":"165ra162","DOI":"10.1126\/scitranslmed.3004108","volume":"4","author":"S Corti","year":"2012","unstructured":"Corti, S.  et al. Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy. Sci. Transl Med. 4, 165ra162 (2012).","journal-title":"Sci. Transl Med."},{"key":"BFnrneurol2017126_CR173","doi-asserted-by":"crossref","first-page":"72ra18","DOI":"10.1126\/scitranslmed.3001777","volume":"3","author":"MA Passini","year":"2011","unstructured":"Passini, M. A.  et al. Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy. Sci. Transl Med. 3, 72ra18 (2011).","journal-title":"Sci. Transl Med."},{"key":"BFnrneurol2017126_CR174","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/hmg\/ddr600","volume":"21","author":"PN Porensky","year":"2012","unstructured":"Porensky, P. N.  et al. A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse. Hum. Mol. Genet. 21, 1625\u20131638 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol2017126_CR175","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0140-6736(90)92148-B","volume":"336","author":"C Wijmenga","year":"1990","unstructured":"Wijmenga, C.  et al. Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet 336, 651\u2013653 (1990).","journal-title":"Lancet"},{"key":"BFnrneurol2017126_CR176","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/hmg\/2.12.2037","volume":"2","author":"JC van Deutekom","year":"1993","unstructured":"van Deutekom, J. C.  et al. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum. Mol. Genet. 2, 2037\u20132042 (1993).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol2017126_CR177","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0092-8674(02)00826-7","volume":"110","author":"D Gabellini","year":"2002","unstructured":"Gabellini, D., Green, M. R. & Tupler, R. Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 110, 339\u2013348 (2002).","journal-title":"Cell"},{"key":"BFnrneurol2017126_CR178","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1189044","volume":"329","author":"RJ Lemmers","year":"2010","unstructured":"Lemmers, R. J.  et al. A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 329, 1650\u20131653 (2010).","journal-title":"Science"},{"key":"BFnrneurol2017126_CR179","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/ng1262","volume":"35","author":"PG van Overveld","year":"2003","unstructured":"van Overveld, P. G.  et al. Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat. Genet. 35, 315\u2013317 (2003).","journal-title":"Nat. Genet."},{"key":"BFnrneurol2017126_CR180","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.molmed.2015.02.011","volume":"21","author":"A Lek","year":"2015","unstructured":"Lek, A., Rahimov, F., Jones, P. L. & Kunkel, L. M. Emerging preclinical animal models for FSHD. Trends Mol. Med. 21, 295\u2013306 (2015).","journal-title":"Trends Mol. Med."},{"key":"BFnrneurol2017126_CR181","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/jmg.33.5.366","volume":"33","author":"R Tupler","year":"1996","unstructured":"Tupler, R.  et al. Monosomy of distal 4q does not cause facioscapulohumeral muscular dystrophy. J. Med. Genet. 33, 366\u2013370 (1996).","journal-title":"J. Med. Genet."},{"key":"BFnrneurol2017126_CR182","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mus.20522","volume":"34","author":"R Tawil","year":"2006","unstructured":"Tawil, R. & Van Der Maarel, S. M. Facioscapulohumeral muscular dystrophy. Muscle Nerve 34, 1\u201315 (2006).","journal-title":"Muscle Nerve"},{"key":"BFnrneurol2017126_CR183","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ana.22275","volume":"69","author":"LM Wallace","year":"2011","unstructured":"Wallace, L. M.  et al. DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann. Neurol. 69, 540\u2013552 (2011).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2017126_CR184","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/mt.2013.263","volume":"22","author":"SN Pandey","year":"2014","unstructured":"Pandey, S. N., Lee, Y. C., Yokota, T. & Chen, Y. W. Morpholino treatment improves muscle function and pathology of Pitx1 transgenic mice. Mol. Ther. 22, 390\u2013396 (2014).","journal-title":"Mol. Ther."},{"key":"BFnrneurol2017126_CR185","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature04422","volume":"439","author":"D Gabellini","year":"2006","unstructured":"Gabellini, D.  et al. Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. Nature 439, 973\u2013977 (2006).","journal-title":"Nature"},{"key":"BFnrneurol2017126_CR186","doi-asserted-by":"crossref","first-page":"e0117665","DOI":"10.1371\/journal.pone.0117665","volume":"10","author":"SJ Feeney","year":"2015","unstructured":"Feeney, S. J.  et al. FHL1 reduces dystrophy in transgenic mice overexpressing FSHD muscular dystrophy region gene 1 (FRG1). PLoS ONE 10, e0117665 (2015).","journal-title":"PLoS ONE"},{"key":"BFnrneurol2017126_CR187","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1038\/mt.2011.153","volume":"19","author":"S Bortolanza","year":"2011","unstructured":"Bortolanza, S.  et al. AAV6-mediated systemic shRNA delivery reverses disease in a mouse model of facioscapulohumeral muscular dystrophy. Mol. Ther. 19, 2055\u20132064 (2011).","journal-title":"Mol. Ther."},{"key":"BFnrneurol2017126_CR188","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/mt.2012.68","volume":"20","author":"LM Wallace","year":"2012","unstructured":"Wallace, L. M.  et al. RNA interference inhibits DUX4-induced muscle toxicity in vivo: implications for a targeted FSHD therapy. Mol. Ther. 20, 1417\u20131423 (2012).","journal-title":"Mol. Ther."},{"key":"BFnrneurol2017126_CR189","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/mt.2015.200","volume":"24","author":"CL Himeda","year":"2015","unstructured":"Himeda, C. L., Jones, T. I. & Jones, P. L. CRISPR\/dCas9-mediated transcriptional inhibition ameliorates the epigenetic dysregulation at D4Z4 and represses DUX4-fl in FSH muscular dystrophy. Mol. Ther. 24, 527\u2013535 (2015).","journal-title":"Mol. Ther."},{"key":"BFnrneurol2017126_CR190","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tig.2015.02.003","volume":"31","author":"GF Richard","year":"2015","unstructured":"Richard, G. F. Shortening trinucleotide repeats using highly specific endonucleases: a possible approach to gene therapy? Trends Genet. 31, 177\u2013186 (2015).","journal-title":"Trends Genet."},{"key":"BFnrneurol2017126_CR191","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.drudis.2014.09.011","volume":"20","author":"BM Godinho","year":"2015","unstructured":"Godinho, B. M., Malhotra, M., O'Driscoll, C. M. & Cryan, J. F. Delivering a disease-modifying treatment for Huntington's disease. Drug Discov. Today 20, 50\u201364 (2015).","journal-title":"Drug Discov. Today"},{"key":"BFnrneurol2017126_CR192","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s004380050031","volume":"261","author":"GF Richard","year":"1999","unstructured":"Richard, G. F., Dujon, B. & Haber, J. E. Double-strand break repair can lead to high frequencies of deletions within short CAG\/CTG trinucleotide repeats. Mol. Gen. Genet. 261, 871\u2013882 (1999).","journal-title":"Mol. Gen. Genet."},{"key":"BFnrneurol2017126_CR193","doi-asserted-by":"crossref","first-page":"9607","DOI":"10.1073\/pnas.0902420106","volume":"106","author":"D Mittelman","year":"2009","unstructured":"Mittelman, D.  et al. Zinc-finger directed double-strand breaks within CAG repeat tracts promote repeat instability in human cells. Proc. Natl Acad. Sci. USA 106, 9607\u20139612 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2017126_CR194","doi-asserted-by":"crossref","first-page":"E3136","DOI":"10.1073\/pnas.1206506109","volume":"109","author":"M Garriga-Canut","year":"2012","unstructured":"Garriga-Canut, M.  et al. Synthetic zinc finger repressors reduce mutant huntingtin expression in the brain of R6\/2 mice. Proc. Natl Acad. Sci. USA 109, E3136\u2013E3145 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2017126_CR195","doi-asserted-by":"crossref","first-page":"e95611","DOI":"10.1371\/journal.pone.0095611","volume":"9","author":"GF Richard","year":"2014","unstructured":"Richard, G. F.  et al. Highly specific contractions of a single CAG\/CTG trinucleotide repeat by TALEN in yeast. PLoS ONE 9, e95611 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrneurol2017126_CR196","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/nrneurol.2015.33","volume":"11","author":"G De Michele","year":"2015","unstructured":"De Michele, G. & Filla, A. Movement disorders: Friedreich ataxia today \u2014 preparing for the final battle. Nat. Rev. Neurol. 11, 188\u2013190 (2015).","journal-title":"Nat. Rev. Neurol."},{"key":"BFnrneurol2017126_CR197","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","volume":"271","author":"V Campuzano","year":"1996","unstructured":"Campuzano, V.  et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271, 1423\u20131427 (1996).","journal-title":"Science"},{"key":"BFnrneurol2017126_CR198","doi-asserted-by":"crossref","first-page":"14044","DOI":"10.1038\/mtm.2014.44","volume":"1","author":"C Gerard","year":"2014","unstructured":"Gerard, C.  et al. An AAV9 coding for frataxin clearly improved the symptoms and prolonged the life of Friedreich ataxia mouse models. Mol. Ther. Methods Clin. Dev. 1, 14044 (2014).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"BFnrneurol2017126_CR199","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1038\/mtna.2013.41","volume":"2","author":"P Chapdelaine","year":"2013","unstructured":"Chapdelaine, P., Coulombe, Z., Chikh, A., Gerard, C. & Tremblay, J. P. A potential new therapeutic approach for Friedreich ataxia: induction of frataxin expression with TALE proteins. Mol. Ther. Nucleic Acids 2, e119 (2013).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"BFnrneurol2017126_CR200","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/mt.2015.41","volume":"23","author":"YJ Li","year":"2015","unstructured":"Li, Y. J.  et al. Excision of expanded GAA repeats alleviates the molecular phenotype of Friedreich's ataxia. Mol. Ther. 23, 1055\u20131065 (2015).","journal-title":"Mol. Ther."},{"key":"BFnrneurol2017126_CR201","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1056\/NEJM196212202672501","volume":"267","author":"M Victor","year":"1962","unstructured":"Victor, M., Hayes, R. & Adams, R. D. Oculopharyngeal muscular dystrophy. A familial disease of late life characterized by dysphagia and progressive ptosis of the eyelids. N. Engl. J. Med. 267, 1267\u20131272 (1962).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol2017126_CR202","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng0298-164","volume":"18","author":"B Brais","year":"1998","unstructured":"Brais, B.  et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat. Genet. 18, 164\u2013167 (1998).","journal-title":"Nat. Genet."},{"key":"BFnrneurol2017126_CR203","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/hmg\/4.3.429","volume":"4","author":"B Brais","year":"1995","unstructured":"Brais, B.  et al. The oculopharyngeal muscular dystrophy locus maps to the region of the cardiac alpha and beta myosin heavy chain genes on chromosome 14q11.2\u2013q13. Hum. Mol. Genet. 4, 429\u2013434 (1995).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol2017126_CR204","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/hmg\/11.9.1107","volume":"11","author":"B Ravikumar","year":"2002","unstructured":"Ravikumar, B., Duden, R. & Rubinsztein, D. C. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum. Mol. Genet. 11, 1107\u20131117 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol2017126_CR205","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bbadis.2006.10.003","volume":"1772","author":"A Abu-Baker","year":"2007","unstructured":"Abu-Baker, A. & Rouleau, G. A. Oculopharyngeal muscular dystrophy: recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies. Biochim. Biophys. Acta 1772, 173\u2013185 (2007).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrneurol2017126_CR206","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/hmg\/ddi422","volume":"15","author":"JE Davies","year":"2006","unstructured":"Davies, J. E., Sarkar, S. & Rubinsztein, D. C. Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy. Hum. Mol. Genet. 15, 23\u201331 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol2017126_CR207","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02015481\n                    \n                   (2016)."},{"key":"BFnrneurol2017126_CR208","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/mt.2013.155","volume":"22","author":"S Perie","year":"2014","unstructured":"Perie, S.  et al. Autologous myoblast transplantation for oculopharyngeal muscular dystrophy: a phase I\/IIa clinical study. Mol. Ther. 22, 219\u2013225 (2014).","journal-title":"Mol. Ther."},{"key":"BFnrneurol2017126_CR209","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1089\/hum.2015.014","volume":"26","author":"P Harish","year":"2015","unstructured":"Harish, P., Malerba, A., Dickson, G. & Bachtarzi, H. Progress on gene therapy, cell therapy, and pharmacological strategies toward the treatment of oculopharyngeal muscular dystrophy. Hum. Gene Ther. 26, 286\u2013292 (2015).","journal-title":"Hum. Gene Ther."},{"key":"BFnrneurol2017126_CR210","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/humu.1380010302","volume":"1","author":"P Shelbourne","year":"1992","unstructured":"Shelbourne, P. & Johnson, K. Myotonic dystrophy: another case of too many repeats? Hum. Mutat. 1, 183\u2013189 (1992).","journal-title":"Hum. Mutat."},{"key":"BFnrneurol2017126_CR211","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1126\/science.1546325","volume":"255","author":"M Mahadevan","year":"1992","unstructured":"Mahadevan, M.  et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3\u2032 untranslated region of the gene. Science 255, 1253\u20131255 (1992).","journal-title":"Science"},{"key":"BFnrneurol2017126_CR212","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/355545a0","volume":"355","author":"HG Harley","year":"1992","unstructured":"Harley, H. G.  et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 355, 545\u2013546 (1992).","journal-title":"Nature"},{"key":"BFnrneurol2017126_CR213","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0092-8674(92)90154-5","volume":"68","author":"JD Brook","year":"1992","unstructured":"Brook, J. D.  et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3\u2032 end of a transcript encoding a protein kinase family member. Cell 68, 799\u2013808 (1992).","journal-title":"Cell"},{"key":"BFnrneurol2017126_CR214","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S1474-4422(12)70204-1","volume":"11","author":"B Udd","year":"2012","unstructured":"Udd, B. & Krahe, R. The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol. 11, 891\u2013905 (2012).","journal-title":"Lancet Neurol."},{"key":"BFnrneurol2017126_CR215","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/stem.1970","volume":"33","author":"G Xia","year":"2015","unstructured":"Xia, G.  et al. Genome modification leads to phenotype reversal in human myotonic dystrophy type 1 induced pluripotent stem cell-derived neural stem cells. Stem Cells 33, 1829\u20131838 (2015).","journal-title":"Stem Cells"},{"key":"BFnrneurol2017126_CR216","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/mt.2013.251","volume":"22","author":"W Zhang","year":"2014","unstructured":"Zhang, W.  et al. Treatment of type 1 myotonic dystrophy by engineering site-specific RNA endonucleases that target (CUG)n repeats. Mol. Ther. 22, 312\u2013320 (2014).","journal-title":"Mol. Ther."},{"key":"BFnrneurol2017126_CR217","doi-asserted-by":"crossref","first-page":"50ra69","DOI":"10.1126\/scitranslmed.3000951","volume":"2","author":"M Krahn","year":"2010","unstructured":"Krahn, M.  et al. A naturally occurring human minidysferlin protein repairs sarcolemmal lesions in a mouse model of dysferlinopathy. Sci. Transl Med. 2, 50ra69 (2010).","journal-title":"Sci. Transl Med."},{"key":"BFnrneurol2017126_CR218","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/acn3.172","volume":"2","author":"PC Sondergaard","year":"2015","unstructured":"Sondergaard, P. C.  et al. AAV.dysferlin overlap vectors restore function in dysferlinopathy animal models. Ann. Clin. Transl Neurol. 2, 256\u2013270 (2015).","journal-title":"Ann. Clin. Transl Neurol."},{"key":"BFnrneurol2017126_CR219","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/hmg\/ddq065","volume":"19","author":"W Lostal","year":"2010","unstructured":"Lostal, W.  et al. Efficient recovery of dysferlin deficiency by dual adeno-associated vector-mediated gene transfer. Hum. Mol. Genet. 19, 1897\u20131907 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol2017126_CR220","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02710500\n                    \n                   (2016)."},{"key":"BFnrneurol2017126_CR221","doi-asserted-by":"crossref","first-page":"140ra189","DOI":"10.1126\/scitranslmed.3003541","volume":"4","author":"FS Tedesco","year":"2012","unstructured":"Tedesco, F. S.  et al. Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy. Sci. Transl Med. 4, 140ra189 (2012).","journal-title":"Sci. Transl Med."},{"key":"BFnrneurol2017126_CR222","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/mt.2016.40","volume":"24","author":"S Turan","year":"2016","unstructured":"Turan, S., Farruggio, A. P., Srifa, W., Day, J. W. & Calos, M. P. Precise correction of disease mutations in induced pluripotent stem cells derived from patients with limb girdle muscular dystrophy. Mol. Ther. 24, 685\u2013696 (2016).","journal-title":"Mol. Ther."},{"key":"BFnrneurol2017126_CR223","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/156652312802083585","volume":"12","author":"J Liu","year":"2012","unstructured":"Liu, J. & Harper, S. Q. RNAi-based gene therapy for dominant limb girdle muscular dystrophies. Curr. Gene Ther. 12, 307\u2013314 (2012).","journal-title":"Curr. Gene Ther."},{"key":"BFnrneurol2017126_CR224","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1038\/mtna.2014.13","volume":"3","author":"J Liu","year":"2014","unstructured":"Liu, J.  et al. RNAi-mediated gene silencing of mutant myotilin improves myopathy in LGMD1A mice. Mol. Ther. Nucleic Acids 3, e160 (2014).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"BFnrneurol2017126_CR225","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1002\/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T","volume":"23","author":"RD Cohn","year":"2000","unstructured":"Cohn, R. D. & Campbell, K. P. Molecular basis of muscular dystrophies. Muscle Nerve 23, 1456\u20131471 (2000).","journal-title":"Muscle Nerve"},{"key":"BFnrneurol2017126_CR226","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.nmd.2007.02.008","volume":"17","author":"A Oldfors","year":"2007","unstructured":"Oldfors, A. Hereditary myosin myopathies. Neuromuscul. Disord. 17, 355\u2013367 (2007).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017126_CR227","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1750-3639.2009.00289.x","volume":"19","author":"R Schroder","year":"2009","unstructured":"Schroder, R. & Schoser, B. Myofibrillar myopathies: a clinical and myopathological guide. Brain Pathol. 19, 483\u2013492 (2009).","journal-title":"Brain Pathol."},{"key":"BFnrneurol2017126_CR228","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.nmd.2011.10.003","volume":"22","author":"B Udd","year":"2012","unstructured":"Udd, B. Distal myopathies \u2014 new genetic entities expand diagnostic challenge. Neuromuscul. Disord. 22, 5\u201312 (2012).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017126_CR229","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s11910-013-0434-4","volume":"14","author":"B Udd","year":"2014","unstructured":"Udd, B. Distal myopathies. Curr. Neurol. Neurosci. Rep. 14, 434 (2014).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"BFnrneurol2017126_CR230","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/nm.4367","volume":"23","author":"DU Kemaladewi","year":"2017","unstructured":"Kemaladewi, D. U.  et al. Correction of a splicing defect in a mouse model of congenital muscular dystrophy type 1A using a homology-directed-repair-independent mechanism. Nat. Med. 23, 984\u2013989 (2017).","journal-title":"Nat. Med."},{"key":"BFnrneurol2017126_CR231","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/hgtb.2013.151","volume":"25","author":"CH Vannoy","year":"2014","unstructured":"Vannoy, C. H.  et al. Adeno-associated virus-mediated overexpression of LARGE rescues \u03b1-dystroglycan function in dystrophic mice with mutations in the fukutin-related protein. Hum. Gene Ther. Methods 25, 187\u2013196 (2014).","journal-title":"Hum. Gene Ther. Methods"},{"key":"BFnrneurol2017126_CR232","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1089\/hum.2012.084","volume":"24","author":"M Yu","year":"2013","unstructured":"Yu, M.  et al. Adeno-associated viral-mediated LARGE gene therapy rescues the muscular dystrophic phenotype in mouse models of dystroglycanopathy. Hum. Gene Ther. 24, 317\u2013330 (2013).","journal-title":"Hum. Gene Ther."},{"key":"BFnrneurol2017126_CR233","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1038\/mtna.2013.39","volume":"2","author":"L Xu","year":"2013","unstructured":"Xu, L., Zhao, P., Mariano, A. & Han, R. Targeted myostatin gene editing in multiple mammalian species directed by a single pair of TALE nucleases. Mol. Ther. Nucleic Acids 2, e112 (2013).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"BFnrneurol2017126_CR234","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.addr.2014.02.010","volume":"73","author":"KF Buckland","year":"2014","unstructured":"Buckland, K. F. & Bobby Gaspar, H. Gene and cell therapy for children \u2014 new medicines, new challenges? Adv. Drug Deliv. Rev. 73, 162\u2013169 (2014).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"BFnrneurol2017126_CR235","doi-asserted-by":"crossref","first-page":"14038","DOI":"10.1038\/mtm.2014.38","volume":"1","author":"AL Arnett","year":"2014","unstructured":"Arnett, A. L.  et al. Adeno-associated viral vectors do not efficiently target muscle satellite cells. Mol. Ther. Methods Clin. Dev. 1, 14038 (2014).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"BFnrneurol2017126_CR236","doi-asserted-by":"crossref","first-page":"14040","DOI":"10.1038\/mtm.2014.40","volume":"1","author":"DH Stitelman","year":"2014","unstructured":"Stitelman, D. H.  et al. Developmental stage determines efficiency of gene transfer to muscle satellite cells by in utero delivery of adeno-associated virus vector serotype 2\/9. Mol. Ther. Methods Clin. Dev. 1, 14040 (2014).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"BFnrneurol2017126_CR237","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/mt.2009.253","volume":"18","author":"E Kimura","year":"2010","unstructured":"Kimura, E., Li, S., Gregorevic, P., Fall, B. M. & Chamberlain, J. S. Dystrophin delivery to muscles of mdx mice using lentiviral vectors leads to myogenic progenitor targeting and stable gene expression. Mol. Ther. 18, 206\u2013213 (2010).","journal-title":"Mol. Ther."},{"key":"BFnrneurol2017126_CR238","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt.3117","volume":"33","author":"SQ Tsai","year":"2015","unstructured":"Tsai, S. Q.  et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR\u2013Cas nucleases. Nat. Biotechnol. 33, 187\u2013197 (2015).","journal-title":"Nat. Biotechnol."},{"key":"BFnrneurol2017126_CR239","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nmeth.2857","volume":"11","author":"B Shen","year":"2014","unstructured":"Shen, B.  et al. Efficient genome modification by CRISPR\u2013Cas9 nickase with minimal off-target effects. Nat. Methods 11, 399\u2013402 (2014).","journal-title":"Nat. Methods"},{"key":"BFnrneurol2017126_CR240","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aad5227","volume":"351","author":"IM Slaymaker","year":"2016","unstructured":"Slaymaker, I. M.  et al. Rationally engineered Cas9 nucleases with improved specificity. Science 351, 84\u201388 (2016).","journal-title":"Science"},{"key":"BFnrneurol2017126_CR241","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","volume":"529","author":"BP Kleinstiver","year":"2016","unstructured":"Kleinstiver, B. P.  et al. High-fidelity CRISPR\u2013Cas9 nucleases with no detectable genome-wide off-target effects. Nature 529, 490\u2013495 (2016).","journal-title":"Nature"},{"key":"BFnrneurol2017126_CR242","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","volume":"122","author":"F Mingozzi","year":"2013","unstructured":"Mingozzi, F. & High, K. A. Immune responses to AAV vectors: overcoming barriers to successful gene therapy. Blood 122, 23\u201336 (2013).","journal-title":"Blood"},{"key":"BFnrneurol2017126_CR243","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nm1549","volume":"13","author":"F Mingozzi","year":"2007","unstructured":"Mingozzi, F.  et al. CD8+ T-cell responses to adeno-associated virus capsid in humans. Nat. Med. 13, 419\u2013422 (2007).","journal-title":"Nat. Med."},{"key":"BFnrneurol2017126_CR244","doi-asserted-by":"crossref","first-page":"194ra192","DOI":"10.1126\/scitranslmed.3005795","volume":"5","author":"F Mingozzi","year":"2013","unstructured":"Mingozzi, F.  et al. Overcoming preexisting humoral immunity to AAV using capsid decoys. Sci. Transl Med. 5, 194ra192 (2013).","journal-title":"Sci. Transl Med."},{"key":"BFnrneurol2017126_CR245","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1099\/vir.0.014175-0","volume":"90","author":"D Madsen","year":"2009","unstructured":"Madsen, D., Cantwell, E. R., O'Brien, T., Johnson, P. A. & Mahon, B. P. Adeno-associated virus serotype 2 induces cell-mediated immune responses directed against multiple epitopes of the capsid protein VP1. J. Gen. Virol. 90, 2622\u20132633 (2009).","journal-title":"J. Gen. Virol."},{"key":"BFnrneurol2017126_CR246","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1172\/JCI68205","volume":"123","author":"SM Faust","year":"2013","unstructured":"Faust, S. M.  et al. CpG-depleted adeno-associated virus vectors evade immune detection. J. Clin. Invest. 123, 2994\u20133001 (2013).","journal-title":"J. Clin. Invest."},{"key":"BFnrneurol2017126_CR247","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/mt.2013.218","volume":"22","author":"TL Wu","year":"2014","unstructured":"Wu, T. L.  et al. CD8+ T cell recognition of epitopes within the capsid of adeno-associated virus 8-based gene transfer vectors depends on vectors' genome. Mol. Ther. 22, 42\u201351 (2014).","journal-title":"Mol. Ther."},{"key":"BFnrneurol2017126_CR248","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nmeth.3993","volume":"13","author":"WL Chew","year":"2016","unstructured":"Chew, W. L.  et al. A multifunctional AAV-CRISPR\u2013Cas9 and its host response. Nat. Methods 13, 868\u2013874 (2016).","journal-title":"Nat. Methods"},{"key":"BFnrneurol2017126_CR249","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJMoa1000228","volume":"363","author":"JR Mendell","year":"2010","unstructured":"Mendell, J. R.  et al. Dystrophin immunity in Duchenne's muscular dystrophy. N. Engl. J. Med. 363, 1429\u20131437 (2010).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2017.126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2017.126","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nrneurol.2017.126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2017.126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:20:51Z","timestamp":1684470051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2017.126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,29]]},"references-count":249,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["BFnrneurol2017126"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2017.126","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,29]]},"assertion":[{"value":"29 September 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.A.G., C.E.N. and J.R.H. are inventors on patent applications related to genome engineering for neuromuscular diseases.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}